Genmab A (GMAB) Retained Earnings (2019 - 2026)
Genmab A (GMAB) posted Retained Earnings of -$340.0 million for Q1 2026, down 87.85% on a QoQ basis from -$181.0 million in Q4 2025, and down 59.62% year-over-year from -$842.1 million in Q1 2025.
Genmab A (GMAB) Retained Earnings (2019 - 2026) Analysis & Trends
Genmab A's Retained Earnings history runs 6 years deep, the most recent figure standing at -$340.0 million for Q1 2026.
- Quarterly Retained Earnings fell 59.62% year-over-year to -$340.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$340.0 million (down 59.62% YoY) and the FY2025 annual result came in at -$181.0 million, up 19.91% from the prior year.
- Retained Earnings was -$340.0 million for Q1 2026 at Genmab A, down from -$181.0 million in the prior quarter.
- Across five years, Retained Earnings topped out at $2.7 billion in Q4 2023 and bottomed at -$340.0 million in Q1 2026.
- A 4-year average of $194.7 million and a median of -$210.0 million in 2025 frame the typical range for Retained Earnings.
- Annual changes were most pronounced in 2024 — Retained Earnings plunged 108.26% — and 2025, when it advanced 19.91%.
- Genmab A's Retained Earnings stood at $2.7 billion in 2023, then plunged by 108.26% to -$226.0 million in 2024, then climbed by 19.91% to -$181.0 million in 2025, then plunged by 87.85% to -$340.0 million in 2026.
- Business Quant data shows GMAB's Retained Earnings at -$340.0 million in Q1 2026, -$181.0 million in Q4 2025, and -$204.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -527.87 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -27.89 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 12.91 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 115.82 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 14.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 11.90 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -622,000.00 |
| 10 | Genmab A | 1.89 Bn | 366.92 Mn | 831.00 Mn | -340.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -340.00 Mn |
| Dec 31, 2025 | -181.00 Mn |
| Sep 30, 2025 | -204.00 Mn |
| Jun 30, 2025 | -210.00 Mn |
| Mar 31, 2025 | -213.00 Mn |
| Dec 31, 2024 | -226.00 Mn |
| Dec 31, 2023 | 2.74 Bn |
| Sep 30, 2020 | 74.00 |
| Dec 31, 2019 | 98.00 |
| Sep 30, 2019 | 100.39 Mn |